3-substituted pyrido(4',3':4,5)thieno(2,3-d)pyrimidine derivatives, their preparation and their use
CA 2265509 A1 · Owner: Wicke, Karsten · Inventors: Kerrigan, Frank; Bach, Alfred; Emling, Franz
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns 3-substituted 3,4,5,6,7,8-hexahydropyrido4,3':4,5thieno-2,3-dpyrimidine derivatives of formula (I) in which: R1 designates a hydrogen atom, a C1-C4 alkyl group an acetyl or benzoyl , group, a phenylalkyl C1-C4 group - the aromatic optionally being substituted by halogen, C1-C4 alkyl, trifluoromethyl hydroxy, C1-C4 alkoxy, amino, cyano , or nitro groups - a naphthylalkyl C1-C3 group a phenylalkanone C2-C3 group or , a phenylcarbamoylalkyl C2 group wherein the phenyl group can be substituted by halogen; R2 designates a phenyl, pyridyl pyrimidinyl or pyrazinyl group , which can optionally be monodi- or tri-substituted by halogen atoms C1-C4 , alkyl, trifluoromethyl, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 22, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 22, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 22, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.